Attached files

file filename
10-K - 10-K - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20141231x10k.htm
EX-10.20 - FORM OF SEVERANCE AND CHANGE IN EFFECTIVE CONTROL AGREEMENT - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela_xseverancexandxcha.htm
EX-10.21 - 2014 EQUITY INCENTIVE PLAN (AS AMENDED) - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela_2014xequityxincent.htm
EX-10.23 - 2002 STOCK OPTION PLAN/RESTRICTED STOCK PLAN LETTER - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela_2002xplanxletterxp.htm
EX-10.22 - 2012 EQUITY INCENTIVE PLAN LETTER - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela_2012xplanxletterxp.htm
EX-32.2 - CERTIFICATION - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20141231xexhibit322.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20141231xexhibit312.htm
EX-32.1 - CERTIFICATION - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20141231xexhibit321.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20141231xexhibit311.htm
EXCEL - IDEA: XBRL DOCUMENT - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDFinancial_Report.xls
EX-10.19 - FIRST AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN THE CO. AND BRIAN O'CALLAGHAN - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDo_callaghanxfirstxamendmen.htm
EXHIBIT 23.01


Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-193811) of Acucela Inc. of our reports dated March 30, 2015, with respect to the financial statements and the effectiveness of internal control over financial reporting of Acucela Inc. included in this Annual Report (Form 10-K) of Acucela Inc. for the year ended December 31, 2014.

/s/ Ernst & Young LLP
Seattle, Washington
March 30, 2015